Literature DB >> 3545632

A comparison of three anti-double stranded DNA antibody assays on sera from SLE and other diseases.

M C Clarke, R Carr, N M Burdash, Z Y Chen, S K Ainsworth.   

Abstract

Systemic lupus erythematosus (SLE) is a multisystem disorder accompanied by a diverse spectrum of serum autoantibodies. Antibodies to double stranded DNA (dsDNA) are considered to be the most specific marker for this disease. In this study the results obtained from three different assays for dsDNA are compared: an indirect fluorescence antibody assay (IFA), a radioimmunoassay (RIA) and, an enzyme-linked immunosorbent assay (ELISA), on 57 SLE sera and 28 Sera from other disorders. Correlation of these anti-DNA results are made with C3, C4, and antinuclear antibody (ANA) titers. Our results show the IFA assay is the most sensitive and the least specific of the three tests. The RIA was found to be the most specific and was approximately as sensitive as the ELISA. We also found significant inverse correlations between anti-dsDNA levels and circulating complement levels among SLE sera for all three assays. ANA titers were significantly correlated with all anti-dsDNA assays as well. However, these anti-dsDNA assays show only modest differences explainable by numerous mechanisms. Hence, a clearly superior anti-dsDNA method does not emerge from our study.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3545632

Source DB:  PubMed          Journal:  Diagn Immunol        ISSN: 0735-3111


  7 in total

1.  Anti-double-stranded DNA antibodies in the healthy elderly: prevalence and characteristics.

Authors:  A Ruffatti; A Calligaro; T Del Ross; M T Bertoli; A Doria; L Rossi; S Todesco
Journal:  J Clin Immunol       Date:  1990-11       Impact factor: 8.317

2.  Lack of specificity for antibodies to double stranded DNA found in four commercial kits.

Authors:  M Kadlubowski; M Jackson; P L Yap; G Neill
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

3.  Evaluation of five commercial kits to detect dsDNA antibodies.

Authors:  S A McMillan; A C Fay
Journal:  J Clin Pathol       Date:  1988-11       Impact factor: 3.411

4.  Clinical importance of persistence of anticardiolipin antibodies in systemic lupus erythematosus.

Authors:  Y Ishii; K Nagasawa; T Mayumi; Y Niho
Journal:  Ann Rheum Dis       Date:  1990-06       Impact factor: 19.103

5.  Clinical manifestations and antiphosphatidylserine antibodies in patients with systemic lupus erythematosus: is there an association?

Authors:  Mehmet Sahin; Nursen Duzgun; Sevket Ercan Tunc; Huseyin Tutkak
Journal:  Clin Rheumatol       Date:  2006-04-06       Impact factor: 2.980

6.  Presence of antibodies to ubiquitin during the autoimmune response associated with systemic lupus erythematosus.

Authors:  S Muller; J P Briand; M H Van Regenmortel
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  Interkit Reproducibility of the Indirect Immunofluorescence Assay on HEp-2 Cells Depends on the Immunofluorescence Reactivity Intensity and Pattern.

Authors:  Mônica Jesus Silva; Alessandra Dellavance; Danielle Cristiane Baldo; Silvia Helena Rodrigues; Marcelle Grecco; Monica Simon Prado; Renan Agustinelli; Luís Eduardo Coelho Andrade
Journal:  Front Immunol       Date:  2022-01-19       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.